Search or
𝛼SK
𝛼SKSign in with Google. Opens in new tab
bullish
Progyny (PGNY US): Q2 Results Ahead of Expectations; 2022 Guidance Raised Second Time This Year
415 Views12 Aug 2022 08:28
SUMMARY
- Progyny Inc (PGNY US) announced strong Q2 results, with both revenue and EPS surpassing consensus as well as company guidance. Revenue and adjusted EBITDA margin reached to highest ever levels.
- The company has raised lower end of its 2022 revenue and adjusted EBITDA guidance second time in this year. Progyny is seeing continued strong employer demand for fertility solutions.
- Despite inflation and a potential softening in the economy, Progyny is seeing strong customer demand and is upbeat about new client acquisition for its upcoming selling season.
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Hang Seng Indexes: Announcement Tomorrow; Potential Changes & Updated Flows
- Daiichi Sankyo Placement - US$1.2bn Deal but Momentum Isn’t the Best, Last Deal Didn’t Do Well
- First Pacific (142 HK) Is Fully Valued Here
- US Government May Acquire Equity Stakes in Samsung Electronics and TSMC
- HK-Listed Apparel & Footwear Screener Aug 2025: Lever Style (1346 HK) Conference Call
Top Unpaywalled Insights
More »- India-China Economic Relations: Navigating Massive Imbalances and Strategic Dependencies
- Kyivstar (KYIV US): Structural Long – From Ukraine’s Resilience to Renewal; Uklon Embedded Value
- How to Own Lenovo at a Discount: BUY Legend Holdings Corp (3396 HK)
- Institutions Are Coming for Bitcoin — UTXO’s Loren Asmus Explains How
- Curator's Cut: Singapore Unlocks Value, India’s Jewellery Caution & Taiwan's Top ETF's Rebalance
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
x